Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Anticholesteremic Agents Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Vitrectomy Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Coronary Vessels Medicine & Life Sciences
Japan Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Cross-Sectional Studies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2017

8 Citations

Ezetimibe in combination with statins ameliorates endothelial dysfunction in coronary arteries after stenting: the CuVIC trial (effect of cholesterol absorption inhibitor usage on target vessel dysfunction after coronary stenting), a multicenter randomized controlled trial

Takase, S., Matoba, T., Nakashiro, S., Mukai, Y., Inoue, S., Oi, K., Higo, T., Katsuki, S., Takemoto, M., Suematsu, N., Eshima, K., Miyata, K., Yamamoto, M., Usui, M., Sadamatsu, K., Satoh, S., Kadokami, T., Hironaga, K., Ichi, I., Todaka, K. & 3 othersKishimoto, J., Egashira, K. & Sunagawa, K., Feb 2017, In : Arteriosclerosis, thrombosis, and vascular biology. 37, 2, p. 350-358 9 p.

Research output: Contribution to journalArticle

Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Coronary Vessels
Randomized Controlled Trials
Coronary Angiography

Impact of Risk-Benefit Perception and Trust on Medical Technology Acceptance in Relation to Drug and Device Lag: A Tripartite Cross-Sectional Survey

Todaka, K., Kishimoto, J., Ikeda, M., Ikeda, K. & Yamamoto, H., Jan 1 2017, (Accepted/In press) In : Therapeutic Innovation and Regulatory Science. 52, 5, p. 629-640 12 p.

Research output: Contribution to journalArticle

Japan
Cross-Sectional Studies
Technology
Equipment and Supplies
Pharmaceutical Preparations

Efficacy and Safety of A0001 (Brilliant Blue G250) for Internal Limiting Membrane Staining and Peeling: Phase III Investigator-initiated Multicenter Clinical Trial

Enaida, H., Hirakata, A., Ohji, M., Nishida, K., Kubota, T., Ogata, N., Sonoda, K., Uchiyama, M., Kishimoto, J., Todaka, K., Nakanishi, Y. & Ishibashi, T., Jun 1 2016, In : Nippon Ganka Gakkai zasshi. 120, 6, p. 439-448 10 p.

Research output: Contribution to journalArticle

Vitrectomy
Multicenter Studies
Research Personnel
Clinical Trials
Staining and Labeling